Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Ludwig Rasche"'
Autor:
Anna Chorschew, Firat Kesgin, Judith Bellmann-Strobl, Peter Flachenecker, Insa Schiffmann, Friederike Rosenthal, Patrick Althoff, Daniel Drebinger, Radina Arsenova, Ludwig Rasche, Eva-Maria Dorsch, Christoph Heesen, Friedemann Paul, Jan-Patrick Stellmann, Tanja Schmitz-Hübsch
Publikováno v:
Health and Quality of Life Outcomes, Vol 21, Iss 1, Pp 1-12 (2023)
Abstract Background Gait impairment is a relevant problem in persons with multiple sclerosis (pwMS). The Multiple Sclerosis Walking Scale 12 (MSWS-12) is a valid Patient Reported Outcome Measure (PROM) to evaluate walking ability in pwMS. The aim of
Externí odkaz:
https://doaj.org/article/f4ac443d2e3443d9b97e18b000f6669d
Autor:
Inmaculada Toboso, Amalia Tejeda-Velarde, Roberto Alvarez-Lafuente, Rafael Arroyo, Harald Hegen, Florian Deisenhammer, Susana Sainz de la Maza, José C. Alvarez-Cermeño, Guillermo Izquierdo, Dolores Paramo, Pedro Oliva, Bonaventura Casanova, Eduardo Agüera-Morales, Diego Franciotta, Matteo Gastaldi, Oscar Fernández, Patricia Urbaneja, José M. Garcia-Dominguez, Fernando Romero, Alicia Laroni, Antonio Uccelli, Angel Perez-Sempere, Albert Saiz, Yolanda Blanco, Daniela Galimberti, Elio Scarpini, Carmen Espejo, Xavier Montalban, Ludwig Rasche, Friedemann Paul, Inés González, Elena Álvarez, Cristina Ramo, Ana B. Caminero, Yolanda Aladro, Carmen Calles, Pablo Eguía, Antonio Belenguer-Benavides, Lluis Ramió-Torrentà, Ester Quintana, José E. Martínez-Rodríguez, Agustín Oterino, Carlos López de Silanes, Luis I. Casanova, Lamberto Landete, Jette Frederiksen, Gabriel Bsteh, Patricia Mulero, Manuel Comabella, Miguel A. Hernández, Mercedes Espiño, José M. Prieto, Domingo Pérez, María Otano, Francisco Padilla, Juan A. García-Merino, Laura Navarro, Alfonso Muriel, Lucienne Costa Frossard, Luisa M. Villar
Publikováno v:
Frontiers in Neurology, Vol 11 (2020)
Overview: We assessed the role of age and disease activity as new factors contributing to establish the risk of progressive multifocal leucoencephalopathy in multiple sclerosis patients treated with natalizumab in 36 University Hospitals in Europe. W
Externí odkaz:
https://doaj.org/article/c82f6fa684d240fe86a6b469a1788aa1
Autor:
Daniel Drebinger, Ludwig Rasche, Daniel Kroneberg, Patrik Althoff, Judith Bellmann-Strobl, Martin Weygandt, Friedemann Paul, Alexander U. Brandt, Tanja Schmitz-Hübsch
Publikováno v:
Frontiers in Neurology, Vol 11 (2020)
Background: Fatigue in multiple sclerosis (MS) is conceived as a multidimensional construct.Objectives: This study aims to describe the changes of balance and gait parameters after 6 min of walking (6 MW) as potential quantitative markers for percept
Externí odkaz:
https://doaj.org/article/f77cdaf06211488cb71bfb66325729b3
Autor:
Karen Otte, Tobias Ellermeyer, Tim-Sebastian Vater, Marlen Voigt, Daniel Kroneberg, Ludwig Rasche, Theresa Krüger, Hanna Maria Röhling, Bastian Kayser, Sebastian Mansow-Model, Fabian Klostermann, Alexander Ulrich Brandt, Friedemann Paul, Axel Lipp, Tanja Schmitz-Hübsch
Publikováno v:
Sensors, Vol 20, Iss 19, p 5465 (2020)
Fluctuations of motor symptoms make clinical assessment in Parkinson’s disease a complex task. New technologies aim to quantify motor symptoms, and their remote application holds potential for a closer monitoring of treatment effects. The focus of
Externí odkaz:
https://doaj.org/article/43fbdbb1effd42a38b33b840a8bd41ad
Autor:
Ludwig Rasche, Michael Scheel, Karen Otte, Patrik Althoff, Annemieke B. van Vuuren, Rene M. Gieß, Joseph Kuchling, Judith Bellmann-Strobl, Klemens Ruprecht, Friedemann Paul, Alexander U. Brandt, Tanja Schmitz-Hübsch
Publikováno v:
Frontiers in Neurology, Vol 9 (2018)
Introduction: Brain atrophy is a widely accepted marker of disease severity with association to clinical disability in multiple sclerosis (MS). It is unclear to which extent this association reflects common age effects on both atrophy and function.Ob
Externí odkaz:
https://doaj.org/article/b112fbd002264d8db477e4a12ef177c1
Autor:
René M Gieß, Catherina Pfuhl, Janina R Behrens, Ludwig Rasche, Erik Freitag, Nima Khalighy, Carolin Otto, Jens Wuerfel, Alexander U Brandt, Jörg Hofmann, Bettina Eberspächer, Judith Bellmann-Strobl, Friedemann Paul, Klemens Ruprecht
Publikováno v:
PLoS ONE, Vol 12, Iss 4, p e0175279 (2017)
To investigate the association of Epstein-Barr virus (EBV) nuclear antigen-1 (EBNA-1) and viral capsid antigen (VCA) immunoglobulin (Ig)G antibodies in serum as well as EBV DNA load in saliva with radiological and clinical disease activity in patient
Externí odkaz:
https://doaj.org/article/4176a55cff814a6e8a92462f197a14b0
Autor:
Ludwig Rasche, Lisa Heiserich, Janina Ruth Behrens, Klaus Lenz, Catherina Pfuhl, Katharina Wakonig, René Markus Gieß, Erik Freitag, Caroline Eberle, Jens Wuerfel, Jan Dörr, Peter Bauer, Judith Bellmann-Strobl, Friedemann Paul, Dirk Roggenbuck, Klemens Ruprecht
Publikováno v:
PLoS ONE, Vol 11, Iss 1, p e0147968 (2016)
BACKGROUND:In response to DNA double-strand breaks, the histone protein H2AX becomes phosphorylated at its C-terminal serine 139 residue, referred to as γ-H2AX. Formation of γ-H2AX foci is associated with recruitment of p53-binding protein 1 (53BP1
Externí odkaz:
https://doaj.org/article/65d7438056b149d29e45545d44831cac
Autor:
Catherina Pfuhl, Ludwig Rasche, Alexander U. Brandt, Judith Bellmann-Strobl, Ulrike Grittner, Friedemann Paul, Michael Scheel, Janina Behrens, Klemens Ruprecht, Florence Pache, René M. Gieß, Rüdiger Wenzel, Johanna Oechtering
Publikováno v:
Neurology. 93:e1439-e1451
ObjectivesTo evaluate intrathecal immunoglobulin M (IgM) production, as compared to previously established risk factors, as risk factor for conversion from clinically isolated syndrome (CIS) to multiple sclerosis (MS) and to explore the association o
Autor:
Friedemann Paul, Ludwig Rasche
Publikováno v:
Expert Opinion on Pharmacotherapy. 19:2073-2086
Ozanimod is a selective sphingosine 1-phosphate receptor 1 and 5 modulator under development by Celgene, for the treatment of relapsing remitting multiple sclerosis. Extensive clinical experience has become available for the related compound fingolim
Autor:
Friedemann Paul, Angel Perez-Sempere, Oscar Fernandez, Alicia Laroni, Miguel A Hernández, Domingo Pérez, Matteo Gastaldi, Susana Sainz de la Maza, Guillermo Izquierdo, Mercedes Espiño, Gabriel Bsteh, Antonio Belenguer-Benavides, Jose E Martínez-Rodríguez, Eduardo Agüera-Morales, Luisa M. Villar, Inmaculada Toboso, Florian Deisenhammer, Cristina Ramo, Patricia Urbaneja, Laura Navarro, Pedro Oliva, Inés González, J.A. García-Merino, Bonaventura Casanova, Ludwig Rasche, Albert Saiz, Agustín Oterino, Antonio Uccelli, Daniela Galimberti, J.C. Álvarez-Cermeño, Manuel Comabella, Carmen Espejo, Jette L. Frederiksen, Harald Hegen, J.M. Prieto, José M. García-Domínguez, Francisco Padilla, Luis I Casanova, Xavier Montalban, Carmen Calles, Lamberto Landete, Diego Franciotta, Ester Quintana, Patricia Mulero, Elio Scarpini, Rafael Arroyo, Roberto Alvarez-Lafuente, Fernando Romero, Yolanda Aladro, Amalia Tejeda-Velarde, Alfonso Muriel, Lucienne Costa Frossard, Lluís Ramió-Torrentà, María Otano, Yolanda Blanco, Carlos López de Silanes, Dolores Paramo, Elena Álvarez, Ana B Caminero, Pablo Eguía
Publikováno v:
Frontiers in Neurology
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
r-FISABIO. Repositorio Institucional de Producción Científica
instname
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
Toboso, I, Tejeda-Velarde, A, Alvarez-Lafuente, R, Arroyo, R, Hegen, H, Deisenhammer, F, Sainz de la Maza, S, Alvarez-Cermeño, J C, Izquierdo, G, Paramo, D, Oliva, P, Casanova, B, Agüera-Morales, E, Franciotta, D, Gastaldi, M, Fernández, O, Urbaneja, P, Garcia-Dominguez, J M, Romero, F, Laroni, A, Uccelli, A, Perez-Sempere, A, Saiz, A, Blanco, Y, Galimberti, D, Scarpini, E, Espejo, C, Montalban, X, Rasche, L, Paul, F, González, I, Álvarez, E, Ramo, C, Caminero, A B, Aladro, Y, Calles, C, Eguía, P, Belenguer-Benavides, A, Ramió-Torrentà, L, Quintana, E, Martínez-Rodríguez, J E, Oterino, A, López de Silanes, C, Casanova, L I, Landete, L, Frederiksen, J, Bsteh, G, Mulero, P, Comabella, M, Hernández, M A, Espiño, M, Prieto, J M, Pérez, D, Otano, M, Padilla, F, García-Merino, J A, Navarro, L, Muriel, A, Frossard, L C & Villar, L M 2020, ' New Algorithms Improving PML Risk Stratification in MS Patients Treated With Natalizumab ', Frontiers in Neurology, vol. 11, 579438 . https://doi.org/10.3389/fneur.2020.579438
Frontiers in Neurology, Vol 11 (2020)
Frontiers in neurology
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
r-FISABIO. Repositorio Institucional de Producción Científica
instname
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
Toboso, I, Tejeda-Velarde, A, Alvarez-Lafuente, R, Arroyo, R, Hegen, H, Deisenhammer, F, Sainz de la Maza, S, Alvarez-Cermeño, J C, Izquierdo, G, Paramo, D, Oliva, P, Casanova, B, Agüera-Morales, E, Franciotta, D, Gastaldi, M, Fernández, O, Urbaneja, P, Garcia-Dominguez, J M, Romero, F, Laroni, A, Uccelli, A, Perez-Sempere, A, Saiz, A, Blanco, Y, Galimberti, D, Scarpini, E, Espejo, C, Montalban, X, Rasche, L, Paul, F, González, I, Álvarez, E, Ramo, C, Caminero, A B, Aladro, Y, Calles, C, Eguía, P, Belenguer-Benavides, A, Ramió-Torrentà, L, Quintana, E, Martínez-Rodríguez, J E, Oterino, A, López de Silanes, C, Casanova, L I, Landete, L, Frederiksen, J, Bsteh, G, Mulero, P, Comabella, M, Hernández, M A, Espiño, M, Prieto, J M, Pérez, D, Otano, M, Padilla, F, García-Merino, J A, Navarro, L, Muriel, A, Frossard, L C & Villar, L M 2020, ' New Algorithms Improving PML Risk Stratification in MS Patients Treated With Natalizumab ', Frontiers in Neurology, vol. 11, 579438 . https://doi.org/10.3389/fneur.2020.579438
Frontiers in Neurology, Vol 11 (2020)
Frontiers in neurology
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
Overview: We assessed the role of age and disease activity as new factors contributing to establish the risk of progressive multifocal leucoencephalopathy in multiple sclerosis patients treated with natalizumab in 36 University Hospitals in Europe. W
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef36835f42e2ef0f7c67c0021ce9224e
https://fundanet.fisabio.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=8697
https://fundanet.fisabio.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=8697